These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
256 related items for PubMed ID: 20868679
21. Identification of fetal gender in maternal blood is a helpful tool in the prenatal diagnosis of haemophilia. Santacroce R, Vecchione G, Tomaiyolo M, Sessa F, Sarno M, Colaizzo D, Grandone E, Margaglione M. Haemophilia; 2006 Jul; 12(4):417-22. PubMed ID: 16834744 [Abstract] [Full Text] [Related]
24. Application of real-time PCR of sex-independent insertion-deletion polymorphisms to determine fetal sex using cell-free fetal DNA from maternal plasma. Ho SS, Barrett A, Thadani H, Asibal CL, Koay ES, Choolani M. Clin Chem Lab Med; 2015 Jul; 53(8):1189-95. PubMed ID: 25581758 [Abstract] [Full Text] [Related]
25. Maternal urine for prenatal diagnosis--an analysis of cell-free fetal DNA in maternal urine and plasma in the third trimester. Majer S, Bauer M, Magnet E, Strele A, Giegerl E, Eder M, Lang U, Pertl B. Prenat Diagn; 2007 Dec; 27(13):1219-23. PubMed ID: 17968856 [Abstract] [Full Text] [Related]
31. SRY-specific cell free fetal DNA in maternal plasma in twin pregnancies throughout gestation. Orendi K, Klein K, Krampl-Bettelheim E, Nuk M, Holzapfel-Bauer M, Magnet E, Griesbacher A, Lang U, Pertl B. Placenta; 2011 Aug; 32(8):611-5. PubMed ID: 21696822 [Abstract] [Full Text] [Related]
36. Mrassf1a-pap, a novel methylation-based assay for the detection of cell-free fetal DNA in maternal plasma. van den Oever JM, Balkassmi S, Segboer T, Verweij EJ, van der Velden PA, Oepkes D, Bakker E, Boon EM. PLoS One; 2013 Aug; 8(12):e84051. PubMed ID: 24391879 [Abstract] [Full Text] [Related]
39. RASSF1A in maternal plasma as a molecular marker of preeclampsia. Papantoniou N, Bagiokos V, Agiannitopoulos K, Kolialexi A, Destouni A, Tounta G, Kanavakis E, Antsaklis A, Mavrou A. Prenat Diagn; 2013 Jul; 33(7):682-7. PubMed ID: 23526657 [Abstract] [Full Text] [Related]
40. Follow-up of gestational trophoblastic disease/neoplasia via quantification of circulating nucleic acids of placental origin using C19MC microRNAs, hypermethylated RASSF1A, and SRY sequences. Hromadnikova I, Kotlabova K, Krofta L, Hron F. Tumour Biol; 2017 Apr; 39(4):1010428317697548. PubMed ID: 28381180 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]